Elsa G. Barbacci

911 total citations
8 papers, 767 citations indexed

About

Elsa G. Barbacci is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elsa G. Barbacci has authored 8 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elsa G. Barbacci's work include HER2/EGFR in Cancer Research (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Elsa G. Barbacci is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Elsa G. Barbacci collaborates with scholars based in United States and Canada. Elsa G. Barbacci's co-authors include James D. Moyer, Kenneth K. Iwata, Leslie R. Pustilnik, Vincent A. Pollack, John A. Davis, Michael J. Morin, Lee D. Arnold, Deborah A. Baker, Teresa A. Smolarek and Konstantinos Tsaparikos and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

Elsa G. Barbacci

8 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elsa G. Barbacci United States 6 396 376 215 120 98 8 767
Stefan Jenewein Germany 10 493 1.2× 380 1.0× 54 0.3× 115 1.0× 145 1.5× 14 871
D M Barnes United Kingdom 15 591 1.5× 298 0.8× 102 0.5× 153 1.3× 16 0.2× 21 1.1k
Yasuyuki Kirii Japan 13 116 0.3× 284 0.8× 54 0.3× 32 0.3× 15 0.2× 18 582
Carina Fung Australia 10 462 1.2× 884 2.4× 158 0.7× 11 0.1× 48 0.5× 14 1.0k
Yuching Chen United States 6 220 0.6× 573 1.5× 79 0.4× 42 0.3× 12 0.1× 7 736
Montserrat Carrasco‐Triguero United States 14 313 0.8× 258 0.7× 24 0.1× 387 3.2× 34 0.3× 26 716
Venkata Ramana Doppalapudi United States 14 102 0.3× 334 0.9× 25 0.1× 119 1.0× 185 1.9× 21 626
Amber M. Johnson United States 13 251 0.6× 272 0.7× 155 0.7× 21 0.2× 18 0.2× 20 702
Zhen Tong United Kingdom 8 206 0.5× 453 1.2× 61 0.3× 14 0.1× 52 0.5× 10 714
Frédéric Frénois France 12 66 0.2× 418 1.1× 22 0.1× 27 0.2× 97 1.0× 23 658

Countries citing papers authored by Elsa G. Barbacci

Since Specialization
Citations

This map shows the geographic impact of Elsa G. Barbacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa G. Barbacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa G. Barbacci more than expected).

Fields of papers citing papers by Elsa G. Barbacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsa G. Barbacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa G. Barbacci. The network helps show where Elsa G. Barbacci may publish in the future.

Co-authorship network of co-authors of Elsa G. Barbacci

This figure shows the co-authorship network connecting the top 25 collaborators of Elsa G. Barbacci. A scholar is included among the top collaborators of Elsa G. Barbacci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsa G. Barbacci. Elsa G. Barbacci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lin, Lin, Brandon Tan, Paul Pantapalangkoor, et al.. (2012). Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis. mBio. 3(5). 125 indexed citations
2.
Jani, Jitesh P., Elsa G. Barbacci, Samit K. Bhattacharya, et al.. (2004). Discovery and development of CP-724714, a selective HER2 receptor tyrosine kinase inhibitor. Journal of Clinical Oncology. 22(14_suppl). 3122–3122. 3 indexed citations
3.
Barbacci, Elsa G., Leslie R. Pustilnik, Ann Marie Rossi, et al.. (2003). The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.. PubMed. 63(15). 4450–9. 40 indexed citations
4.
Pollack, Vincent A., Deborah A. Baker, Konstantinos Tsaparikos, et al.. (1999). Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice. Journal of Pharmacology and Experimental Therapeutics. 291(2). 739–748. 369 indexed citations
5.
Barbacci, Elsa G., et al.. (1995). The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding. Journal of Biological Chemistry. 270(16). 9585–9589. 79 indexed citations
6.
Schnur, Rodney C., Michael L. Corman, Randall J. Gallaschun, et al.. (1995). erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships. Journal of Medicinal Chemistry. 38(19). 3813–3820. 110 indexed citations
7.
Barbacci, Elsa G., et al.. (1995). The structural basis for the specificity of epidermal growth factor and heregulin binding.. Journal of Biological Chemistry. 270(47). 28494–28494. 1 indexed citations
8.
Schnur, Rodney C., et al.. (1994). Binding of Benzoquinoid Ansamycins to p100 Correlates with Their Ability to Deplete the erbB2 Gene Product p185. Biochemical and Biophysical Research Communications. 201(3). 1313–1319. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026